Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies

Feb 10, 2022

- Feb 9, 2023

1.0

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

The Expanding Role of FcRn Blockers to Achieve Minimal Symptom Expression in Patients with...

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists